This school explores the intersection of autism, apraxia, motor planning, speech development, immune activation, inflammation, and environmental exposures. It is framed as educational and exploratory. Autism is not described as a biotoxin illness, and no causation or cure is claimed. The school examines how immune and environmental factors may intersect with neurodevelopmental conditions — as a question for study, not a conclusion.
Educational exploration of autism, apraxia, motor planning, neuroinflammation, and brain-body communication — framed as exploratory, not causal.
Anticipated release: January 2027.
Understanding apraxia, motor planning challenges, and their relationship to neurodevelopment and brain-body communication. Anticipated release: January 2027.
Educational exploration of how immune activation and inflammation may intersect with autism, framed as exploratory rather than causal. Anticipated release: January 2027.
The intersection of communication challenges, emotional regulation, and immune system stress in neurodevelopmental conditions. Anticipated release: January 2027.
Examining the role of environmental exposure in the autism population and what current research suggests. Anticipated release: January 2027.
How neuroinflammation may intersect with neurodevelopmental conditions, presented as an educational framework for further study. Anticipated release: January 2027.
A foundational course for parents and caregivers exploring the intersection of autism, apraxia, and immune/environmental factors. Anticipated release: January 2027.
Educational content only. Biotoxin University does not provide medical advice, diagnosis, treatment, lab interpretation, or environmental clearance decisions. Consult qualified professionals for personal decisions.